Investment Summary

Exits Targacept

On April 1, 2006, invested in life science company Targacept from Easton Capital Investment Group

Investment Highlights
  • This is transaction in the Life Science sector.
  • This is transaction in the United States.
  • This is transaction in North Carolina.
Investment Fate
  • Targacept merged with another company in 2015.

Investment Summary
Date 2006-04-01
Target Targacept
Sector Life Science
Sellers(s) Easton Capital Investment Group
Deal Type IPO

Target

Targacept

Winston-Salem, North Carolina, United States
website
Targacept, Inc. is a R&D pharmaceutical company. Targacept is involved with the development and commercialization of drugs based on selective activation of a previously unexploited class of targets - neuronal nicotinic acetylcholine receptors (NNRs). These drugs offer a new way to treat various major CNS and gastrointestinal diseases and disorders including Alzheimer's Disease, depression and ulcerative colitis.

Search 177,534 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Seller(S) 1

SELLER

Easton Capital Investment Group

New York, New York, United States

Investor Investor Investor Investor Investor

website

Category Venture Capital Firm
Founded 2000
PE ASSETS 200M USD
Size Small
Type Sector Focused
DESCRIPTION

Easton Capital Investment Group is a private investment firm that targets early-stage venture capital to later-stage growth capital investments. Easton will consider opportunities across a range of industries but generally invests in the healthcare industry, including biopharmaceuticals, drug delivery, medical devices, and healthcare services. Easton looks to commit $0.50 to $10 million per transaction. Easton Capital was formed in 2000 and is based in New York.

DEAL STATS #
Overall 6 of 20
Sector (Life Science) 4 of 10
Type (IPO) 3 of 6
State (North Carolina) 1 of 2
Country (United States) 6 of 20
Year (2006) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-02-07 IGA Worldwide

New York, New York, United States

IGA Worldwide provides in-game advertising solutions, helping brands to achieve measurable results through its proprietary ad serving network. IGA enables advertisers to target millions of engaged consumers across a broad range of game platforms, titles, and genres. IGA Worldwide is based in New York City.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-11-16 Conor Medsystems

Menlo Park, California, United States

Conor Medsystems, Inc.developed stents and other medical devices as platforms for controlled local and systemic delivery of a wide variety of therapeutic agents. The Company's initial focus was on drug-eluting stents for the treatment of restenosis and vascular disease.

Sell $1.4B
Mergr

Product

Company

Legal